[1] |
Patankar YR, Sutiwisesak R, Boyce S, et al. Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD 8 T cells from the lungs of infected mice. Mucosal Immunol, 2020, 13(1):140-148. doi:10.1038/s41385-019-0217-6.
pmid: 31636345
|
[2] |
World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
|
[3] |
Boom WH, Schaible UE, Achkar JM. The knowns and unknowns of latent Mycobacterium tuberculosis infection. J Clin Invest, 2021, 131(3):e136222. doi:10.1172/JCI136222.
|
[4] |
Ravesloot-Chávez MM, Van Dis E, Stanley SA. The Innate Immune Response to Mycobacterium tuberculosis Infection. Annu Rev Immunol, 2021, 39:611-637. doi:10.1146/annurev-immunol-093019-010426.
pmid: 33637017
|
[5] |
Rai PK, Chodisetti SB, Maurya SK, et al. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-Ⅱ binder peptides elicits protective CD 4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis. J Transl Med, 2018, 16(1):279. doi:10.1186/s12967-018-1653-x.
|
[6] |
Feng D, Chen Y, Dai R, et al. Chromatin organizer SATB 1 controls the cell identity of CD4+ CD8+ double-positive thymocytes by regulating the activity of super-enhancers. Nat Commun, 2022, 13(1):5554. doi:10.1038/s41467-022-33333-6.
|
[7] |
Lindestam Arlehamn CS, Lewinsohn D, Sette A, et al. Antigens for CD4 and CD 8 T cells in tuberculosis. Cold Spring Harb Perspect Med, 2014, 4(7):a018465. doi:10.1101/cshperspect.a018465.
|
[8] |
Swanson RV, Gupta A, Foreman TW, et al. Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Nat Immunol, 2023, 24(5):855-868. doi:10.1038/s41590-023-01476-3.
|
[9] |
Wik JA, Skålhegg BS. T Cell Metabolism in Infection. Front Immunol, 2022, 13:840610. doi:10.3389/fimmu.2022.840610.
|
[10] |
Qin Y, Wang Q, Shi J. Immune checkpoint modulating T cells and NK cells response to Mycobacterium tuberculosis infection. Microbiol Res, 2023, 273:127393. doi:10.1016/j.micres.2023.127393.
|
[11] |
Künzli M, Masopust D. CD4+ T cell memory. Nat Immunol, 2023, 24(6):903-914. doi:10.1038/s41590-023-01510-4.
pmid: 37156885
|
[12] |
Jasenosky LD, Scriba TJ, Hanekom WA, et al. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev, 2015, 264(1):74-87. doi:10.1111/imr.12274.
pmid: 25703553
|
[13] |
闫亚如, 谢建平. 白细胞介素-1在巨噬细胞抗结核分枝杆菌免疫应答及代谢重编程的作用研究进展. 结核与肺部疾病杂志, 2023, 4(6):511-518. doi:10.19983/j.issn.2096-8493.20230108.
|
[14] |
毕秀丽, 耿红, 金瑾. 髓系细胞和CD4+ T细胞在结核分枝杆菌感染和免疫病理中的作用. 中国防痨杂志, 2023, 45(9):904-912. doi:10.19982/j.issn.1000-6621.20230247.
|
[15] |
Gopal R, Monin L, Slight S, et al. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog, 2014, 10(5):e1004099. doi:10.1371/journal.ppat.1004099.
|
[16] |
Van Dis E, Fox DM, Morrison HM, et al. IFN-γ-independent control of M.tuberculosis requires CD 4 T cell-derived GM-CSF and activation of HIF-1α. PLoS Pathog, 2022, 18(7):e1010721. doi:10.1371/journal.ppat.1010721.
|
[17] |
李浩然, 姚丛, 李珊珊, 等. 调节性T细胞在调控抗结核免疫过程中的研究进展. 中华结核和呼吸杂志, 2022, 45(5):502-509. doi:10.3760/cma.j.cn112147-20210830-00609.
|
[18] |
Musvosvi M, Huang H, Wang C, et al. T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. Nat Med, 2023, 29(1):258-269. doi:10.1038/s41591-022-02110-9.
|
[19] |
Sudbury EL, Clifford V, Messina NL, et al. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect, 2020, 81(6):873-881. doi:10.1016/j.jinf.2020.09.032.
pmid: 33007340
|
[20] |
Verma D, Chan ED, Ordway DJ. The double-edged sword of Tregs in M tuberculosis, M avium, and M absessus infection. Immunol Rev, 2021, 301(1):48-61. doi:10.1111/imr.12959.
|
[21] |
Luo Y, Xue Y, Tang G, et al. Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection. Front Immunol, 2021, 12:658843. doi:10.3389/fimmu.2021.658843.
|
[22] |
李丽. 结核病细胞免疫特征研究进展. 中国免疫学杂志, 2017, 33(6): 955-958. doi:10.3969/j.issn.1000-484X.2017.06.032.
|
[23] |
Toulza F, Tsang L, Ottenhoff TH, et al. Mycobacterium tuberculosis-specific CD4+ T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB. Eur J Immunol, 2016, 46(3):752-761. doi:10.1002/eji.201545843.
|
[24] |
Sinha S, Boyden AW, Itani FR, et al. CD8+ T-Cells as Immune Regulators of Multiple Sclerosis. Front Immunol, 2015, 6:619. doi:10.3389/fimmu.2015.00619.
|
[25] |
李威, 刘军, 李慧明, 等. 外周血Treg/IL-17比值变化与肺结核的关系研究. 检验医学与临床, 2023, 20(11): 1519-1521. doi:10.3969/j.issn.1672-9455.2023.11.004.
|
[26] |
Ferreira CM, Barbosa AM, Barreira-Silva P, et al. Early IL-10 promotes vasculature-associated CD4+ T cells unable to control Mycobacterium tuberculosis infection. JCI Insight, 2021, 6(21):e150060. doi:10.1172/jci.insight.150060.
|
[27] |
McCaffrey EF, Donato M, Keren L, et al. The immunoregulatory landscape of human tuberculosis granulomas. Nat Immunol, 2022, 23(2):318-329. doi:10.1038/s41590-021-01121-x.
pmid: 35058616
|
[28] |
Mwebaza I, Shaw R, Li Q, et al. Impact of Mycobacterium tuberculosis Glycolipids on the CD4+ T Cell-Macrophage Immunological Synapse. J Immunol, 2023, 211(9):1385-1396. doi:10.4049/jimmunol.2300107.
pmid: 37695687
|
[29] |
Khan N, Vidyarthi A, Amir M, et al. T-cell exhaustion in tuberculosis: pitfalls and prospects. Crit Rev Microbiol, 2017, 43(2):133-141. doi:10.1080/1040841X.2016.1185603.
pmid: 27800700
|
[30] |
Day CL, Abrahams DA, Bunjun R, et al. PD-1 Expression on Mycobacterium tuberculosis-Specific CD 4 T Cells Is Associated With Bacterial Load in Human Tuberculosis. Front Immunol, 2018, 9:1995. doi:10.3389/fimmu.2018.01995.
|
[31] |
Tezera LB, Bielecka MK, Ogongo P, et al. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α. Elife, 2020, 9:e52668. doi:10.7554/eLife.52668.
|
[32] |
Ogishi M, Yang R, Aytekin C, et al. Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child. Nat Med, 2021, 27(9):1646-1654. doi:10.1038/s41591-021-01388-5.
pmid: 34183838
|
[33] |
Liu K, Wang D, Yao C, et al. Increased Tuberculosis Incidence Due to Immunotherapy Based on PD-1 and PD-L 1 Blockade: A Systematic Review and Meta-Analysis. Front Immunol, 2022, 13:727220. doi:10.3389/fimmu.2022.727220.
|
[34] |
Yang JD, Mott D, Sutiwisesak R, et al. Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages. PLoS Pathog, 2018, 14(5):e1007060. doi:10.1371/journal.ppat.1007060.
|
[35] |
Cai Y, Wang Y, Shi C, et al. Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion. J Exp Med, 2022, 219(3):e20211777. doi:10.1084/jem.20211777.
|
[36] |
Darrah PA, Zeppa JJ, Maiello P, et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature, 2020, 577(7788):95-102. doi:10.1038/s41586-019-1817-8.
|
[37] |
Yang Q, Qi F, Ye T, et al. The interaction of macrophages and CD 8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection. Emerg Microbes Infect, 2023, 12(2):2239940. doi:10.1080/22221751.2023.2239940.
|
[38] |
Lu YJ, Barreira-Silva P, Boyce S, et al. CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection. Cell Rep, 2021, 36(11):109696. doi:10.1016/j.celrep.2021.109696.
|
[39] |
Prezzemolo T, Guggino G, La Manna MP, et al. Functional Signatures of Human CD4 and CD 8 T Cell Responses to Mycobacterium tuberculosis. Front Immunol, 2014, 5:180. doi:10.3389/fimmu.2014.00180.
pmid: 24795723
|
[40] |
Scriba TJ, Netea MG, Ginsberg AM. Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis. Semin Immunol, 2020, 50:101431. doi:10.1016/j.smim.2020.101431.
|
[41] |
Pomaznoy M, Kuan R, Lindvall M, et al. Quantitative and Qualitative Perturbations of CD8+ MAITs in Healthy Mycobacterium tuberculosis-Infected Individuals. Immunohorizons, 2020, 4(6):292-307. doi:10.4049/immunohorizons.2000031.
pmid: 32499216
|
[42] |
唐佩军, 吴妹英. 结核分枝杆菌感染免疫应答与免疫逃逸机制的研究进展. 结核病与肺部健康杂志, 2017, 6(2):181-186. doi:10.3969/j.issn.2095-3755.2017.02.022.
|
[43] |
Wik JA, Skålhegg BS. T Cell Metabolism in Infection. Front Immunol, 2022, 13:840610. doi:10.3389/fimmu.2022.840610.
|
[44] |
Lin PL, Flynn JL. CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol, 2015, 37(3):239-249. doi:10.1007/s00281-015-0490-8.
|
[45] |
Thakur P, Sutiwisesak R, Lu YJ, et al. Use of the Human Granulysin Transgenic Mice To Evaluate the Role of Granulysin Expression by CD 8 T Cells in Immunity To Mycobacterium tuberculosis. mBio, 2022, 13(6):e0302022. doi:10.1128/mbio.03020-22.
|
[46] |
James CA, Xu Y, Aguilar MS, et al. CD4 and CD 8 co-receptors modulate functional avidity of CD1b-restricted T cells. Nat Commun, 2022, 13(1):78. doi:10.1038/s41467-021-27764-w.
|
[47] |
Datta J, Berk E, Cintolo JA, et al. Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy. Front Immunol, 2015, 6:271. doi:10.3389/fimmu.2015.00271.
pmid: 26082780
|
[48] |
Wang Y, Sun Q, Zhang Y, et al. Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas. J Infect, 2023, 86(5):421-438. doi:10.1016/j.jinf.2023.03.020.
pmid: 37003521
|
[49] |
Roy Chowdhury R, Valainis JR, Dubey M, et al. NK-like CD8+ γδ T cells are expanded in persistent Mycobacterium tuberculosis infection. Sci Immunol, 2023, 8(81):eade3525. doi:10.1126/sciimmunol.ade3525.
|
[50] |
Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science, 2003, 300(5617):339-342. doi:10.1126/science.1083317.
pmid: 12690202
|